Sponsor Pipeline

Scholar Rock, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
4
Active Trials
3
Recruiting
1
Phase 3
1
Disease Areas
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-12 NCT07435129
Phase 2 Study Evaluating Apitegromab for the Treatment of FSHD		 Recruitment opened
Active Trials by Phase
Phase 3
1
Phase 2
2
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT05626855 Long-Term Safety & Efficacy of Apitegromab in Patients With SMA Who Completed Previous… Spinal Muscular Atrophy Active, Not Recruiting
Phase 2
NCT07047144 A Study to Evaluate How Apitegromab Works in Subjects Who Are Less Than 2 Years Old and… Spinal Muscular Atrophy Recruiting
NCT07435129 Phase 2 Study Evaluating Apitegromab for the Treatment of FSHD Facioscapulohumeral Muscular Dystrophy Recruiting
Phase 1
NCT07444294 A Single- and Multiple-Ascending Dose Study of SRK-439 in Healthy Adults Healthy Recruiting
Disease Areas
Spinal Muscular Atrophy (2)
Get alerts when Scholar Rock, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free